rewirebio.iobenchmarks
Protocol

Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers

Fragmentia-AI trained on ULP-WGS and six re-implemented fragmentomic feature sets, each with random forest, XGBoost and a deep learning classifier, scored on the same held-out ULP-WGS validation set.

19 evaluations · 19 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

19 recorded evaluations, 19 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

19 evaluations · 19 results. Different protocols are not a single leaderboard.

Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers · Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)

Sorted by AUROC (cancer vs non-cancer, held-out ULP-WGS validation set) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
Fragmentia-AI trained on ULP-WGS (separate instance)Evaluation0.956 (best in column)
DELFI features with XGBoost (Fragmentia-AI paper re-implementation)Evaluation0.935
DELFI features with Deep Learning (Fragmentia-AI paper re-implementation)Evaluation0.932
DELFI features with Random Forest (Fragmentia-AI paper re-implementation)Evaluation0.921
Griffin features with XGBoost (Fragmentia-AI paper re-implementation)Evaluation0.886
Griffin features with Deep Learning (Fragmentia-AI paper re-implementation)Evaluation0.885
Griffin features with Random Forest (Fragmentia-AI paper re-implementation)Evaluation0.881
FRAGMA features with Deep Learning (Fragmentia-AI paper re-implementation)Evaluation0.853
FDI features with Deep Learning (Fragmentia-AI paper re-implementation)Evaluation0.851
FRAGMA features with XGBoost (Fragmentia-AI paper re-implementation)Evaluation0.849
FDI features with Random Forest (Fragmentia-AI paper re-implementation)Evaluation0.847
FDI features with XGBoost (Fragmentia-AI paper re-implementation)Evaluation0.844
FRAGMA features with Random Forest (Fragmentia-AI paper re-implementation)Evaluation0.838
Nucleosome features with Deep Learning (Fragmentia-AI paper re-implementation)Evaluation0.81
Nucleosome features with XGBoost (Fragmentia-AI paper re-implementation)Evaluation0.801
Nucleosome features with Random Forest (Fragmentia-AI paper re-implementation)Evaluation0.793
Subnucleosome features with XGBoost (Fragmentia-AI paper re-implementation)Evaluation0.676
Subnucleosome features with Random Forest (Fragmentia-AI paper re-implementation)Evaluation0.674
Subnucleosome features with Deep Learning (Fragmentia-AI paper re-implementation)Evaluation0.636
All 19 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: DELFI features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.932 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DELFI / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'DELFI' / 'Deep Learning', column 'Performance (AUC)'
Configuration: DELFI features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.921 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DELFI / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'DELFI' / 'Random Forest', column 'Performance (AUC)'
Configuration: DELFI features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.935 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DELFI / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'DELFI' / 'XGBoost', column 'Performance (AUC)'
Configuration: FDI features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.851 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FDI / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FDI' / 'Deep Learning', column 'Performance (AUC)'
Configuration: FDI features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.847 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FDI / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FDI' / 'Random Forest', column 'Performance (AUC)'
Configuration: FDI features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.844 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FDI / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FDI' / 'XGBoost', column 'Performance (AUC)'
Configuration: FRAGMA features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.853 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FRAGMA / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FRAGMA' / 'Deep Learning', column 'Performance (AUC)'
Configuration: FRAGMA features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.838 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FRAGMA / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FRAGMA' / 'Random Forest', column 'Performance (AUC)'
Configuration: FRAGMA features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.849 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FRAGMA / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FRAGMA' / 'XGBoost', column 'Performance (AUC)'
Configuration: Fragmentia-AI trained on ULP-WGS (separate instance)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.956 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cfDNA sequence / Fragmentia-AI on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'cfDNA sequence' / 'Fragmentia-AI', column 'Performance (AUC)'
Configuration: Griffin features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.885 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Griffin / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Griffin' / 'Deep Learning', column 'Performance (AUC)'
Configuration: Griffin features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.881 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Griffin / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Griffin' / 'Random Forest', column 'Performance (AUC)'
Configuration: Griffin features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.886 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Griffin / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Griffin' / 'XGBoost', column 'Performance (AUC)'
Configuration: Nucleosome features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.81 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Nucleosome / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Nucleosome' / 'Deep Learning', column 'Performance (AUC)'
Configuration: Nucleosome features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.793 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Nucleosome / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Nucleosome' / 'Random Forest', column 'Performance (AUC)'
Configuration: Nucleosome features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.801 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Nucleosome / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Nucleosome' / 'XGBoost', column 'Performance (AUC)'
Configuration: Subnucleosome features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.636 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Subnucleosome / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Subnucleosome' / 'Deep Learning', column 'Performance (AUC)'
Configuration: Subnucleosome features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.674 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Subnucleosome / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Subnucleosome' / 'Random Forest', column 'Performance (AUC)'
Configuration: Subnucleosome features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.676 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Subnucleosome / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Subnucleosome' / 'XGBoost', column 'Performance (AUC)'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Explore all linked results

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
1
External evaluations
18

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Training-set class prior where supervised fitting is permitted

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Regularised classifier on simple permitted features, or protocol's conventional reference

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-c8bea25e5abb. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc.

Source locator: Table S5; Results P43-P44

Related records

Suggest a correction